首页> 美国卫生研究院文献>Journal of Analytical Toxicology >Quantification of Ricinine and Abrine in Human Plasma by HPLC-MS/MS: Biomarkers of Exposure to Ricin and Abrin
【2h】

Quantification of Ricinine and Abrine in Human Plasma by HPLC-MS/MS: Biomarkers of Exposure to Ricin and Abrin

机译:HPLC-MS / MS定量测定人血浆中的蓖麻碱和碱:暴露于蓖麻蛋白和阿布林的生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ricin and abrin are toxic ribosome-inactivating proteins found in plants. Exposure to these toxins can be detected using the biomarkers ricinine and abrine, which are present in the same plant sources as the toxins. The concentration of the biomarkers in urine and blood will be dependent upon the purification of abrin or ricin, the route of exposure, and the length of time between exposure and sample collection. Here, we present the first diagnostic assay for the simultaneous quantification of both ricinine and abrine in blood matrices. Furthermore, this is the first-ever method that may detect abrine in blood products. Samples were processed by isotope-dilution, solid-phase extraction, protein precipitation, and quantification by HPLC-MS/MS. This analytical method detects abrine from 5.00 to 500 ng/mL and ricinine from 0.300 to 300 ng/mL with coefficients of determination of 0.996 ± 0.003 and 0.998 ± 0.002 (n=22), respectively. Quality control material accuracy was determined to have less than 10% relative error, and precision was within 19% relative standard deviation. The assay’s time-to-first result is three hours including sample preparation. Furthermore, the method was applied for the quantification of ricinine in the blood of a patient who had intentionally ingested castor beans to demonstrate the test was fit-for-purpose. This assay was designed to support the diagnosis of ricin and abrin exposures in public health investigations.
机译:蓖麻毒素和阿布林是植物中发现的有毒的核糖体失活蛋白。可以使用与毒素相同的植物来源中存在的生物标志物蓖麻碱和阿布林来检测这些毒素的暴露。尿液和血液中生物标志物的浓度将取决于阿布林或蓖麻毒蛋白的纯化,暴露途径以及暴露与样品收集之间的时间长度。在这里,我们提出了同时定量测定血样中蓖麻碱和a碱的第一种诊断方法。此外,这是有史以来第一种可以检测血液制品中的阿布丁的方法。样品通过同位素稀释,固相萃取,蛋白质沉淀和HPLC-MS / MS进行定量处理。该分析方法可检测出5.00至500 ng / mL的阿宾碱和0.300至300 ng / mL的蓖麻碱,测定系数分别为0.996±0.003和0.998±0.002(n = 22)。确定质量控制材料的准确度具有小于10%的相对误差,并且精密度在19%的相对标准偏差内。该方法的首次检测时间为三个小时,包括样品制备。此外,该方法还用于定量摄取了蓖麻子的患者血液中的蓖麻碱含量,以证明该检测是适用的。该分析法旨在支持在公共卫生调查中诊断蓖麻毒素和阿布林暴露。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号